Specifically, the development and progression of fatty liver toward NASH are accelerated by CISD2 haploinsufficiency, which leads to abnormalities in the ER and disturbances in intracellular Ca2+ homeostasis within hepatocytes. This evidence concerns the gene CISD2 and metabolic dysfunction-associated steatohepatitis.